OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
Kinnate Biopharma, Madrigal Pharma, and More Stocks See Action From Activist Investors
2023-11-24 10:00
OrbiMed Advisors is part of a partnership interested in acquiring all of Kinnate Biopharma. Baker Brothers increased an investment in Madrigal Pharmaceuticals.
You Might Like...
Thales awarded multi-year contract for new generation US Passport eCovers
Harpak-ULMA Opens West Coast Customer Experience Center
China Blasts Japan Over Export Curbs on Chipmaking Technology
Archaeologists are too scared to open up the tomb of China’s first emperor
Twitter rival Bluesky hits new milestone
Kyle Bass Urges Investors to Develop Data Centers in a Play for AI
Precisely Announces EngageOne RapidCX, Revolutionizing Customer Communications Management for Highly Regulated Industries
US regulators charge Binance with violating securities laws